In multivariate analysis, only ACE inhibitor or ARB use remained marginally associated with LVEF improvement, and this did not reach statistical significance.
← all excerpts
The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy.
1
—
—